.... my goal is to map out every KOL and their affiliations and ties. If a landscaper is intrigued by Fargo events and PS Targeting, I would imagine that all the Doctors associated with KOL's... well many of them, would naturally be curious why all the focus on PS Targeting at this time with Peregrine Pharmaceuticals.. right?
Big Pharma can't pay off everyone, because everyone knows someone that is affected by cancer, and the best treatment decision must be decided upon. I say it involves PS Targeting.
Claudio Anasetti, MD Scott J. Antonia, MD, PhD Christine M. Pierce Campbell, PhD, MPH W. Douglas Cress, PhD Ellen M. Daley, PhD Kristine A. Donovan, PhD, MBA Peter A. Forsyth, MD Robert A. Gatenby, MD Geoffrey T. Gibney, MD Robert J. Gillies, PhD Anna R. Giuliano, PhD Eric B. Haura, MD Johnathan Mark Lancaster, MD, PhD Christine Laronga, MD, FACS Marino E. Leon, MD Hui-Yi Lin, PhD Anthony M. Magliocco, MD Volker Mai, PhD, MPH Peter G. Medveczky, MD Lynette J. Menezes, PhD Jane L. Messina, MD Alvaro NA Monteiro, PhD James J. Mule, PhD Teresita Munoz-Antonia, PhD Catherine M. Phelan, PhD, MD, MMS Julio M. Pow-Sang, MD Lary Allen Robinson, MD Richard G. Roetzheim, MD, MSPH Dana E. Rollison, PhD Matthew B. Schabath, PhD Ed Seto, PhD David Shibata, MD Erin M. Siegel, PhD, MPH Lubomir Sokol, MD, PhD Philippe E. Spiess, MD
News 
Market Data 
Discover 
